Characterization of a novel trans-activation domain of BRCA1 that functions in concert with the BRCA1 C-terminal (BRCT) domain.
about
BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations.The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activityBRCA1 interacts with FHL2 and enhances FHL2 transactivation functionAttenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor.JunB potentiates function of BRCA1 activation domain 1 (AD1) through a coiled-coil-mediated interactionAntithetic effects of MBD2a on gene regulationBRCA1 associates with processive RNA polymerase IIHomologs of breast cancer genes in plantsAnalysis of missense variation in human BRCA1 in the context of interspecific sequence variationAssessment of human Nter and Cter BRCA1 mutations using growth and localization assays in yeast.A phosphotyrosine switch determines the antitumor activity of ERβ.Classification of BRCA1 missense variants of unknown clinical significance.Functional single-nucleotide polymorphisms in the BRCA1 gene and risk of salivary gland carcinomaSuppression of BRCA1 sensitizes cells to proteasome inhibitors.Genetic suppression reveals DNA repair-independent antagonism between BRCA1 and COBRA1 in mammary gland development.BRCA1, hormone, and tissue-specific tumor suppressionBRCA1 transcriptional activity is enhanced by interactions between its AD1 domain and AhRMultifactorial likelihood assessment of BRCA1 and BRCA2 missense variants confirms that BRCA1:c.122A>G(p.His41Arg) is a pathogenic mutation.Host Cell Reactivation and Transcriptional Activation of Carboplatin-Modified BRCA1.BRCA1 modulates xenobiotic stress-inducible gene expression by interacting with ARNT in human breast cancer cells.Roles of DNA mutation in the coding region and DNA methylation in the 5' flanking region of BRCA1 in canine mammary tumors.A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.Structural basis to characterise transactivation domain of BRCA1
P2860
Q24291985-E684FA12-21F0-443D-BA46-5BDD63A56AE4Q24292058-11692DAF-0ACC-4845-93BC-A9115682AFC6Q24297493-0ED096A5-D2BD-4E18-A626-42FACB5700BDQ24562734-896A51B3-8065-4C9B-A942-018DCE31BB0EQ24675100-52E005B3-65D8-4829-B301-308377F73164Q24684982-86A84D1A-D3C9-4654-8DC6-9A6768D55CEDQ28204666-F0370D04-5758-42D9-8611-5A5EABFB4CCCQ28729894-022BC542-CA61-4267-B391-E22D19B03847Q28764361-DB1276A0-669E-4596-8D6A-4E94E9EE010FQ30407141-AD499F39-C86F-42E6-A92A-194A144BAE62Q33944154-149B100B-89E9-46E0-B0A9-B653A4BFBFF8Q35447780-89B64B22-4B37-4058-9297-73B631A6D2DFQ36129362-8108685D-A455-4F7E-BC8E-B41AB15083A7Q36292025-9F54B577-15A3-431A-AE0F-FBF2EA383769Q36670266-CE4692CE-DC1C-4C08-87B7-A002E6B0394BQ37020551-8AB99EAE-B065-4801-91A2-21EEE825B898Q37242203-C3FFA525-A701-4ECC-B3BE-34889E352443Q37525477-863972A7-BC3E-419A-94E8-13DCCA38B131Q37660257-858C22B4-FDD6-4696-80F2-5221C112D3D9Q40299288-7C289547-15AD-4725-8A79-83D113AF8DDAQ41990672-EABE572A-659E-4F3E-942F-8084C1B88DCFQ43513698-240B1798-9137-4634-9AD6-ECF21A6F523FQ58983792-CDC3B78D-6883-4EF0-9D56-58403401C827
P2860
Characterization of a novel trans-activation domain of BRCA1 that functions in concert with the BRCA1 C-terminal (BRCT) domain.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Characterization of a novel tr ...... RCA1 C-terminal (BRCT) domain.
@ast
Characterization of a novel tr ...... RCA1 C-terminal (BRCT) domain.
@en
type
label
Characterization of a novel tr ...... RCA1 C-terminal (BRCT) domain.
@ast
Characterization of a novel tr ...... RCA1 C-terminal (BRCT) domain.
@en
prefLabel
Characterization of a novel tr ...... RCA1 C-terminal (BRCT) domain.
@ast
Characterization of a novel tr ...... RCA1 C-terminal (BRCT) domain.
@en
P2093
P2860
P356
P1476
Characterization of a novel tr ...... RCA1 C-terminal (BRCT) domain.
@en
P2093
P2860
P304
40910-40915
P356
10.1074/JBC.C000607200
P407
P577
2000-12-01T00:00:00Z